search
Back to results

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer (TIMESPAN)

Primary Purpose

Endometrial Neoplasms

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Time Restricted Eating (TRE) Schedule
Sponsored by
University of Utah
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Endometrial Neoplasms

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

All Aims:

  • Native Hawaiian/Pacific Islander females aged 18 years or older
  • Overweight or obese (BMI>25kg/m2) OR have a history of non-insulin dependent diabetes OR have a history of complex atypical endometrial hyperplasia
  • Have a working cell phone that can download an App
  • Able to use cell phone during day (e.g. at work)
  • Not a night shift worker

Applicable Only to Aims 2 & 3:

  • Able to attend study visits at the Huntsman Cancer Institute Center for HOPE

Exclusion Criteria:

All Aims:

  • Unable to provide informed consent

Applicable Only to Aims 2 & 3:

  • Necessity of a special diet that precludes adjustment of meal timing and/or macronutrient content
  • Have a history of insulin dependent diabetes
  • Have a history of hysterectomy

Sites / Locations

  • Huntsman Cancer InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Time Restricted Eating (TRE) Schedule

Control Schedule

Arm Description

For 8 weeks out of the 14-week randomized dietary crossover study, women will receive prepared frozen lunch and dinner meals as per the control schedule, but will be asked to consume daily meals, snacks, and calories-containing beverages within an 8 to 10-hour period that fits their schedule. The fasting period will ramp up during the first week (Days 1-3, 12-14 h per day, Days 4-6, 14-16 h per day, Days 7+, 16 h per day).

For 4 weeks out of the 14-week randomized dietary crossover study, women will receive prepared frozen lunch and dinner meals, and a standardized breakfast and snacks menu. All meals and snacks will be culturally competent, and meal plans will be individualized to meet weight maintenance energy requirements.

Outcomes

Primary Outcome Measures

Proportion of Women Referred that are Consented
Feasibility of the TRE intervention will be measured by calculating a proportion (%) of women who were referred that were consented into the study. The study will be considered feasible if > 70% of participants are consented and retained.
Attrition as a Function of Time
Number of participants who withdraw throughout the course of the study.
Percent of Scheduled Assessments Completed
Feasibility of the TRE intervention will be assessed by calculating a percentage of scheduled biospecimen collection and questionnaires completed.
Number of TRE-Adherent Days per Week
Feasibility of the TRE intervention will be measured by calculating the number of TRE-adherent days per week. Participants will be considered adherent if they fasted between 14-18 hours per day during the TRE phase according to a mealtime log. The study will be considered feasible if women adhere to the TRE protocol on average 5 days per week.
Percentage of Meals Delivered On Schedule
Feasibility of the TRE intervention will be measured by calculating a percentage of meals delivered on schedule.
Fidelity of Time Restricted Eating (TRE) Intervention
Fidelity will be evaluated as a percentage of protocol checklist items delivered as intended with a goal of 90%.

Secondary Outcome Measures

Change in blood pressure assessed via electronic blood pressure monitor
Blood pressure will be taken using an electronic blood pressure monitor.
Change in waist circumference assessed via measuring tape
Waist circumference will be measured using a measuring tape.
Change in BMI assessed via height and weight
Participants' height and weight will be taken and used to calculate BMI.
Change in fasting blood glucose assessed via blood draw
A small sample of blood will be taken from participants at designated study visits.
Change in HOMA-IR assessed via blood draw
A small sample of blood will be taken from participants at designated study visits.
Change in c-peptide assessed via blood draw
A small sample of blood will be taken from participants at designated study visits.
Change in triglycerides assessed via blood draw
A small sample of blood will be taken from participants at designated study visits.
Change in HDL-cholesterol assessed via blood draw
A small sample of blood will be taken from participants at designated study visits.
Change in high sensitivity C-reactive protein assessed via blood draw
A small sample of blood will be taken from participants at designated study visits.

Full Information

First Posted
February 8, 2021
Last Updated
August 15, 2023
Sponsor
University of Utah
Collaborators
National Center for Advancing Translational Sciences (NCATS)
search

1. Study Identification

Unique Protocol Identification Number
NCT04763902
Brief Title
Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
Acronym
TIMESPAN
Official Title
Feasibility and Acceptability of Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 18, 2021 (Actual)
Primary Completion Date
August 2023 (Anticipated)
Study Completion Date
August 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Utah
Collaborators
National Center for Advancing Translational Sciences (NCATS)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The long-term goal of this study is to determine the efficacy of time restricted eating (TRE) for improving metabolic health and preventing endometrial cancer. The primary objective of the protocol is to conduct a 14-week two-arm randomized crossover trial of a dietary intervention to evaluate the feasibility, fidelity and preliminary acceptability of a TRE intervention among Native Hawaiian/Pacific Islander women at risk for developing endometrial cancer, and to provide proof of principle that TRE can improve metabolic health in this population.
Detailed Description
Enrollment: The study includes two phases. Phase 1 includes focus groups among 30 Native Hawaiian/Pacific Islander women at risk of endometrial cancer. Focus groups will determine sociocultural influences on (i) dietary behavior including meal timing; (ii) dietary preferences; (iii) proposed meal plans and intervention design; (iv) perceptions of weight loss and body image. In the second study phase, the study team will recruit 10 Pacific Islander women to participate in a 14-week randomized dietary crossover study. Each woman will participate in both intervention arms and act as her own control. Focus Group: To accomplish all aspects of Aim 1 of this study, the study team will recruit 30 Pacific Islander women at risk for endometrial cancer to conduct virtual focus groups. These focus groups will take place via private videoconference, like Zoom, and a language translator will be provided, as necessary. The focus groups will be attended by a Native Hawaiian/Pacific Islander Community Expert. Questions will be designed to understand sociocultural influences on dietary behavior (questions on social eating, meal timing, and dietary preferences, soliciting feedback on study intervention delivery design, and perceptions of weight loss and body image). An icebreaker will be conducted prior to formal questioning. Sessions will be audio-recorded on the videoconference and an additional device, transcribed verbatim, and checked for accuracy. Two additional team members will be present as note takers. Our Community Expert will be present to help facilitate the session. Questions will be provided at the beginning of the session to ensure cultural sensitivity. Dietary Intervention: The dietary intervention includes 5 study visits, and features a baseline visit, 2-week run-in period, 4-week control diet schedule, 4-week washout period, and a 4-week, 8 to 10-hour Time Restricted Eating (TRE) protocol (8 to 10-hour feeding and 14 to 16-hour fasting periods). A follow-up questionnaire will be mailed 6-months post- intervention. For the control schedule, women will receive frozen lunch and dinner meals and a standardized breakfast and snacks menu. All meals and the breakfast/snack menu will be designed to be culturally competent with feedback from the focus groups, and meal plans will be individualized to meet weight maintenance energy requirements. For the TRE schedule, women will receive prepared frozen lunch and dinner meals as per the control schedule, but will be asked to consume daily meals, snacks, and calorie-containing beverages within an 8 to 10-hour period that fits their schedule. They will be asked to maintain their regular sleep and physical activity schedule. The fasting period will ramp up during the first week (Days 1-3, 12-14 h per day, Days 4-6, 14-16 h per day, Days 7+, 16 h per day). Women will be asked to schedule the eating period at the same time each day. All meals (control and TRE) will be provided by the Metabolic Kitchen located at the University of Utah. Visit 1: During the baseline visit, a coordinator will obtain consent from the participant, and they will be asked to compete questionnaires asking about clinical and demographic factors, chronotype, and physical activity, and various anthropometric measurements will be taken. Following the baseline visit, participants will undergo a 2-week run-in period. During this time, the goal is to record women's usual times of eating episodes and appetite while following their habitual diet. Visit 2: Women will provide fasting blood and stool samples, and anthropometric measurements will be taken. Following visit 2, participants will undergo the control or TRE schedule for 4 weeks. Visit 3: After 4 weeks, participants will undergo visit 3 and will be asked to provide fasting blood and stool samples, and anthropometric measures will be taken. Following visit 3, participants will undergo a 4-week washout period, where women are able to return to their usual lifestyle. Visit 4: Visit 4 will occur after the 4-week washout period, and will include a telephone consultation to discuss the next study phase and schedule meal provision. For the following 4-weeks, participants will then undergo the opposite feeding schedule (either control or TRE). Visit 5: During the final visit, women will provide fasting blood and stool samples, and anthropometric measures will be taken. During the run-in period, the TRE phase and the control phase, participants will record timing of eating episodes using the MyCircadian Clock phone app, complete 3 x 24-hour diet recalls, a single physical activity recall, and 7-days of sleep and physical activity will be objectively measured using an Actiwatch device. Hunger and satiety will be evaluated at random through the MyCircadian Clock phone app. A study exit interview will be conducted via Zoom conference call to debrief on the intervention and obtain detailed information on acceptability of the protocol. Approximately 6-months after the end of the intervention period, women will complete a mailed follow-up questionnaire.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endometrial Neoplasms

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Time Restricted Eating (TRE) Schedule
Arm Type
Experimental
Arm Description
For 8 weeks out of the 14-week randomized dietary crossover study, women will receive prepared frozen lunch and dinner meals as per the control schedule, but will be asked to consume daily meals, snacks, and calories-containing beverages within an 8 to 10-hour period that fits their schedule. The fasting period will ramp up during the first week (Days 1-3, 12-14 h per day, Days 4-6, 14-16 h per day, Days 7+, 16 h per day).
Arm Title
Control Schedule
Arm Type
No Intervention
Arm Description
For 4 weeks out of the 14-week randomized dietary crossover study, women will receive prepared frozen lunch and dinner meals, and a standardized breakfast and snacks menu. All meals and snacks will be culturally competent, and meal plans will be individualized to meet weight maintenance energy requirements.
Intervention Type
Behavioral
Intervention Name(s)
Time Restricted Eating (TRE) Schedule
Intervention Description
[See arm/group descriptions]
Primary Outcome Measure Information:
Title
Proportion of Women Referred that are Consented
Description
Feasibility of the TRE intervention will be measured by calculating a proportion (%) of women who were referred that were consented into the study. The study will be considered feasible if > 70% of participants are consented and retained.
Time Frame
From baseline to Visit 5 (Week 14)
Title
Attrition as a Function of Time
Description
Number of participants who withdraw throughout the course of the study.
Time Frame
From baseline to Visit 5 (Week 14)
Title
Percent of Scheduled Assessments Completed
Description
Feasibility of the TRE intervention will be assessed by calculating a percentage of scheduled biospecimen collection and questionnaires completed.
Time Frame
From baseline to Visit 5 (Week 14)
Title
Number of TRE-Adherent Days per Week
Description
Feasibility of the TRE intervention will be measured by calculating the number of TRE-adherent days per week. Participants will be considered adherent if they fasted between 14-18 hours per day during the TRE phase according to a mealtime log. The study will be considered feasible if women adhere to the TRE protocol on average 5 days per week.
Time Frame
From baseline to Visit 5 (Week 14)
Title
Percentage of Meals Delivered On Schedule
Description
Feasibility of the TRE intervention will be measured by calculating a percentage of meals delivered on schedule.
Time Frame
From baseline to Visit 5 (Week 14)
Title
Fidelity of Time Restricted Eating (TRE) Intervention
Description
Fidelity will be evaluated as a percentage of protocol checklist items delivered as intended with a goal of 90%.
Time Frame
From baseline to Visit 5 (Week 14)
Secondary Outcome Measure Information:
Title
Change in blood pressure assessed via electronic blood pressure monitor
Description
Blood pressure will be taken using an electronic blood pressure monitor.
Time Frame
Baseline (Visit 1), Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in waist circumference assessed via measuring tape
Description
Waist circumference will be measured using a measuring tape.
Time Frame
Baseline (Visit 1), Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in BMI assessed via height and weight
Description
Participants' height and weight will be taken and used to calculate BMI.
Time Frame
Baseline (Visit 1), Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in fasting blood glucose assessed via blood draw
Description
A small sample of blood will be taken from participants at designated study visits.
Time Frame
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in HOMA-IR assessed via blood draw
Description
A small sample of blood will be taken from participants at designated study visits.
Time Frame
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in c-peptide assessed via blood draw
Description
A small sample of blood will be taken from participants at designated study visits.
Time Frame
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in triglycerides assessed via blood draw
Description
A small sample of blood will be taken from participants at designated study visits.
Time Frame
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in HDL-cholesterol assessed via blood draw
Description
A small sample of blood will be taken from participants at designated study visits.
Time Frame
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)
Title
Change in high sensitivity C-reactive protein assessed via blood draw
Description
A small sample of blood will be taken from participants at designated study visits.
Time Frame
Visit 2 (Week 2), Visit 3 (Week 6), Visit 5 (Week 14)

10. Eligibility

Sex
Female
Gender Based
Yes
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: All Aims: Native Hawaiian/Pacific Islander females aged 18 years or older Overweight or obese (BMI>25kg/m2) OR have a history of non-insulin dependent diabetes OR have a history of complex atypical endometrial hyperplasia Have a working cell phone that can download an App Able to use cell phone during day (e.g. at work) Not a night shift worker Applicable Only to Aims 2 & 3: Able to attend study visits at the Huntsman Cancer Institute Center for HOPE Exclusion Criteria: All Aims: Unable to provide informed consent Applicable Only to Aims 2 & 3: Necessity of a special diet that precludes adjustment of meal timing and/or macronutrient content Have a history of insulin dependent diabetes Have a history of hysterectomy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mary Playdon, PhD, MPH
Phone
(801) 213-6264
Email
mary.playdon@hci.utah.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mary Playdon, PhD, MPH
Organizational Affiliation
University of Utah
Official's Role
Principal Investigator
Facility Information:
Facility Name
Huntsman Cancer Institute
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84112
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mary Playdon, PhD, MPH
Phone
801-213-6264
Email
mary.playdon@hci.utah.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

We'll reach out to this number within 24 hrs